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ABSTRACT
Analysis of Newspaper Coverage of Psilocybin from January 1, 1989 to December 31, 2019
by
Dax Oliver

Advisor: Matthew Gold

Psilocybin is a medicine that has shown the potential to deeply change the treatment of
depression and anxiety (Daniel and Haberman) (Johns Hopkins). However, psilocybin is not
merely a medical issue but a social and political one as well. In the 1960s, public fear about the
effects of psilocybin resulted in severe legal restrictions on its use, even for medical research
(Pollan 217). Today, many psilocybin advocates hope that it will avoid that fate (Haberman).
Measuring public sentiment therefore seems crucial for this community to navigate the social
and legal landscape.
Some studies have examined newspaper coverage to help gauge public sentiment about
other psychoactive compounds (McGinty et al.) (Zhang et al.), but there seems to be no similar
published work yet on psilocybin. Building on these previous studies, I read and hand-coded
every article (a total of 534) mentioning psilocybin from four regional American newspapers
between January 1, 1989 and December 31, 2019. Three main issues were examined: 1) Has
sentiment about psilocybin changed? 2) Has the number of articles mentioning psilocybin
changed? 3) Has there been a change in the use of different terms for psilocybin?
My hand-coded data seemed to indicate that sentiment in these four newspapers has
fluctuated throughout the 30-year period, with a recent significant rise in positivity in only one
newspaper. The number of articles mentioning psilocybin significantly increased in just one
newspaper. The only term for psilocybin with a significant change in use was “hallucinogenic
mushrooms,” which saw a decrease. These results could be a warning to psilocybin advocates
about the risk of negative social and political sentiment eventually growing again, though this is
not conclusive. More investigation of this issue is recommended.
The results of my study are presented in a website at the URL:
https://www.daxoliver.com/tallpear/abstract.
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A Note on Technical Specifications
My capstone project is a research study presented via a website. I built the website with a
self-modified version of the ResponsiveBlogily theme on a WordPress content management
system consisting mostly of HTML, CSS, PHP, and JavaScript code. Data tables are accessible
on the website through links that connect to a WordPress media library.
I coded most of the data visualizations on the website with Vega-Lite, which is a datavisualization grammar using JSON syntax that is built on another data-visualization grammar
called Vega. Both Vega-Lite and Vega were developed by the University of Washington
Interactive Data Lab. Vega largely pulls from the D3.js library. D3.js, in turn, is built using
JavaScript. Vega-Lite accesses the data tables from the capstone research through "raw" copies
saved on a GitHub repository.
Each Vega-Lite data visualization on the website has a bubble in the upper righthand
corner with three grey dots. Clicking on this bubble opens a menu of options for viewers to
experiment themselves with my visualization code and data.
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Introduction and Description of the Capstone Project
Explain the impetus for the capstone
This capstone began four years ago with my parents. In 2016, I read about medical
studies that New York University and Johns Hopkins Medicine had just published about the
chemical compound psilocybin in the Journal of Psychopharmacology (Ross et al.) (Griffiths et
al.). Many previous medical studies, in addition to a vast body of anecdotal evidence, had
reported that psilocybin contained the potential to help alleviate depression and anxiety (Grob et
al.). In addition, some of those studies and anecdotes had found that people who took psilocybin
often reported profound insights into their own mental states, as well as spiritual experiences that
made them feel more connected to the world and people around them (Martin and Hevesi).
The studies at New York University and Johns Hopkins Medicine sought to explore these
potential effects on patients with late-stage terminal cancer. I thought the results of these studies
were remarkable. They found that a single dose of psilocybin, given in a calm and controlled
setting with a licensed therapist, had an enormous impact on most of the study's participants.
Most of the patients reported significantly reduced depression and anxiety concerning their
impending deaths, which were only months away for many of them. Even beyond alleviation of
the symptoms of depression and anxiety, many of the patients reported that the experience had
been one of the most important of their entire lives.
I wondered if psilocybin would be able to help my mother, who had recently been
diagnosed with lung cancer. She wasn't interested when I raised the possibility with her, but the
idea lingered in my memory. My father had suffered a massive stroke several years earlier,
becoming paralyzed and suffering from severe depression and anxiety, so I also considered if he
might benefit from psilocybin like the patients in the NYU and Johns Hopkins studies.
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Unfortunately, psilocybin can be difficult to acquire. Unless you are part of a federally
approved study, the mere possession of psilocybin is illegal almost everywhere in the United
States (as well as much of the rest of the world). This illegality was one of the main reasons why
my mother was too nervous to take psilocybin herself or offer it to my father as his caregiver.
However, when my mother passed away, I became my father's primary caregiver. I offered him
some small doses of psilocybin to see if they might help with the after-effects of his stroke.
These doses were only moderately successful, but the occasional positive effects led me to
continue reading about psilocybin research.
My interest in the therapeutic potential of psilocybin eventually led me to a group of
people on the website Meetup.com. These people regularly met to discuss psilocybin and other
chemical compounds loosely gathered under the name "psychedelics." At one of their meetings,
a doctor gave a lecture about his research into the psychedelic ketamine. Ketamine can be legally
prescribed as a painkiller in the United States and this doctor had often prescribed ketamine for
pain. He had begun to notice that his patients who received ketamine sometimes also showed
reduced depression and anxiety. He had started studying the psychiatric potential of ketamine
and had become so optimistic about its possibilities that he had opened a clinic to provide
ketamine therapy.
After hearing this lecture, I thought that perhaps ketamine therapy could help my father. I
found a ketamine clinic near my father's home and began taking him there for sessions. The
results were often extraordinary. For about a month, he showed noticeably less depression and
anxiety. He also reported less pain. In addition, he regained some of his ability to move his
paralyzed leg. Unfortunately, most of these effects were only temporary, disappearing after the
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first month. However, the results that I saw during that first month of treatment made me think
that ketamine might eventually develop into a widely used therapy.
These experiences with my father and ketamine led me to consider if there was some way
to create a capstone about ketamine therapy. My MALS course on "Digital Humanities" at the
CUNY Graduate Center had shown me how data visualization methods could be used to find
quantifiable information about mass media. Professors Matthew Gold and Stephen Brier taught
me and my fellow students that we could critically examine texts wherever they occurred in
society. During this class I often found myself running newspaper articles through data analysis
software just for my own curiosity. Eventually, these experiments dovetailed with my interest in
ketamine therapy and I wondered if I could examine how newspapers had been treating the
growing use of ketamine therapy for psychological ailments.
There is a tremendous amount of positive thinking among psychedelic advocates that
these chemical compounds will now avoid the stigma that they developed in the 1960s. That
stigma led to many psychedelics, such as psilocybin, being so severely regulated that they could
not be prescribed by doctors for any use. Yet I wondered whether this recent positivity was wellfounded. Although I shared much of the optimism of the psychedelic community, I thought there
was little hard data about public attitudes toward these compounds. I began to wonder if I could
contribute to psychedelic research by using an analysis of newspaper coverage of ketamine
therapy as a window into that medicine's reputation among the general American public.
I spent several months conceptualizing the methods of data analysis and visualization that
have been used in my submitted capstone. Unfortunately, relatively late in my preparations, I
discovered that the research team of Zhang et al. had already published a study examining
newspaper coverage of ketamine therapy. Their focus was so similar to mine that I realized it
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would be very difficult to do my capstone without copying major portions of their work. Thus,
my mind returned to the medicine that had started me down this path in the first place with my
parents – psilocybin. There did not seem to be any published studies on newspaper coverage of
psilocybin. I decided to perform the research for my capstone very similarly to how I had
planned with ketamine, but simply switch the focus to psilocybin. In this way, I was also able to
use the study by Zhang et al. as an example that could help me flesh out the processes of my own
research. Zhang et al. also pointed me in the direction of work by McGinty et al. that had studied
newspaper coverage of opioids.
I felt that building a website would be the best way to present my research. A website
would allow me to create data visualizations that could update themselves if I changed any of the
data. In addition, a website would be more quickly accessible to the wider psilocybin research
and advocacy community.

Describe the aims of the capstone

My capstone research aimed to examine coverage of psilocybin in four regional
American newspapers for the 30-year period from January 1, 1989 to December 31, 2019. I
sought to answer three questions about newspaper coverage:
1) Has sentiment about psilocybin changed?
2) Has the number of articles mentioning psilocybin changed?
3) Has there been a change in the use of different terms for psilocybin?
It should be stressed that these questions are only about newspaper coverage, not general
public sentiment about psilocybin. However, I felt that examining newspaper coverage similarly
to Zhang et al. and McGinty et al. could provide an initial step for psilocybin advocates to gain
perspective on public sentiment. In addition, I recognized the risk that newspapers might no
4

longer be a viable way to accurately gauge media opinion. This seemed especially true
considering the growth of other media outlets such as cable news, podcasts, and YouTube
channels. However, an analysis that took into account the myriad media sources of the modern
era seemed far beyond the scope of a capstone project.
I wanted my study to be as rigorous as possible, so that members of the psilocybin
community could truly benefit from my research. My hope was that my study would, in a small
way at least, inform the actions of both psilocybin researchers and advocates. I also wanted my
capstone to provide information to an audience beyond the psilocybin community. I wanted the
information on the capstone website to be beneficial to anyone curious about psilocybin. To that
end, I provided a concise but thorough explanation of both the science and social/political history
of psilocybin in the United States. If I can contribute to anyone learning about psilocybin in more
depth, even if they are not interested in the specific results of my study, then I will consider my
capstone website to be a success.

URL of the capstone
http://www.daxoliver.com/tallpear/abstract
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Theoretical Framing and/or Methodology Used
Theoretical framing that informed the capstone
This capstone was a reaction to the tremendous optimism among many psilocybin
researchers. As just a few examples of current psilocybin research (in addition to the studies
already mentioned above from New York University and Johns Hopkins Medicine), a study at
the University of California in Los Angeles has examined whether psilocybin can help the
anxiety of patients facing end-stage cancer (Grob et al.). Another peer-reviewed study has
examined the effects of psilocybin in the treatment of alcohol addiction (Bogenschutz et al.).
Johns Hopkins Medicine is currently conducting many studies about psilocybin's potential,
including its impact on depression, anorexia nervosa, nicotine addiction, and Alzheimer's
Disease (Johns Hopkins).
Beyond the scientific community, my capstone is also a reaction to the community of
psilocybin advocates who hope that it will generally gain a more respectable position in
American life. A book about psychedelic research called How to Change Your Mind by
journalist Michael Pollan was a #1 New York Times bestseller in 2018 ("Hardcover Nonfiction").
American companies now openly market psilocybin tours of Jamaica, where possession is legal
(Leonhardt). Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies,
has said: "We are not the counterculture, we are the culture" (Schwartz). Matthew Johnson et al.
have written about psychedelic research that "science has the potential to facilitate innovative
therapeutic breakthroughs by replacing fear and misinformation with scientifically based
conclusions and facts" (166).
However, there was a similar level of optimism about the potential of psilocybin in the
1950s and 1960s. In that era, a great deal of research and activism seemed to be leading toward
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psilocybin becoming part of the regular fabric of American life. However, psilocybin and other
psychedelic compounds soon escaped the rigorous clinical settings (sometimes with the help of
researchers themselves, such as Timothy Leary). Psilocybin started being used by a wide swath
of the public, particularly among teenagers and young adults. A social and political backlash
developed, and the media became filled with lurid stories about the dangers of psychedelic
compounds. In reaction to the fears of many Americans about the effects of psychedelics, the
federal government classified psilocybin as a "Schedule 1" drug in 1970 (Johnson et al.). This
meant that it had no approved medical use in the United States. Not only was it illegal to be
taken recreationally, but not even a doctor could prescribe it. Psilocybin remains a Schedule 1
drug to this day.
Therefore, it seems important for the current era's growing body of research and activism
to be able to gauge the opinion of the American public about psilocybin. Without that gauge, it
seems possible that a social and political backlash could develop once again, removing the
chance for millions of Americans to potentially discover new relief from psychological ailments.
A study to analyze newspaper coverage of psilocybin over the last 30 years seemed like it could
help the psilocybin community in its quest for broader acceptance.

Methodology in dialogue with other scholars
As I discovered, there is already a body of work that has examined newspaper coverage
of psychoactive substances in order to help gauge the sentiment of the American public. In
particular, my study received much of its inspiration from studies by Zhang et al. about ketamine
therapy and McGinty et al. about prescription opioids.
In their analysis of newspaper coverage of opioids in the United States, McGinty et al.
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divided the United States into four geographical regions (Northeast, South, Midwest, and West)
and chose one newspaper from each region. I followed the same format, choosing the New York
Times (Northeast), Tampa Bay Times (South), St. Louis Post-Dispatch (Midwest), and San Diego
Union-Tribune (West). Examining all of these newspapers in total could potentially mitigate
regional differences in sentiment toward psilocybin. Some of these newspapers have absorbed
other newspapers over the time period being examined (January 1, 1989 to December 31, 2019).
Following the example of McGinty et al., the archives of those absorbed newspapers have been
included under the titles of their current publishers.
I chose the four newspapers above because the online media database Nexis Uni (the
academic research portal of the LexisNexis database) had archives of their articles over the time
period being examined. Sets of articles were created by searching Nexis Uni for every article that
mentioned psilocybin. McGinty et al. and Zhang et al. also used aggregated newspaper databases
to compile their articles, as opposed to using the databases of the newspapers themselves
(LexisNexis in the case of McGinty et al. and newspaperarchive.com in the case of Zhang et al.).
In addition, I used Nexis Uni in order to avoid any variations in the quality of databases and
search engines administered by the newspapers themselves.
McGinty et al. and Zhang et al. also helped me realize that I would need to have more
than one category in which to judge the sentiment of individual newspaper articles. Both of these
studies examined several ways in which articles could express sentiment, leading me to create
five sentiment categories specific to psilocybin.

Additional remarks on methodology
When creating sets of articles from Nexis Uni, it was necessary to search for a variety of
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terms in addition to "psilocybin." Although synthetic psilocybin is available, the compound is
often ingested via the mushrooms which naturally contain it. Unlike many other psychoactive
substances, psilocybin is therefore frequently referred to by its delivery container (mushrooms),
even in journalistic contexts. After extensive reading of psilocybin journalism, the present study
chose four search terms for psilocybin: "psilocybin," "magic mushrooms," "hallucinogenic
mushrooms," and "psychedelic mushrooms." Searches were made for both plural and singular
forms. If other common journalistic terms for psilocybin are discovered which are not
represented in the present study, this could be a topic for future research. There are also many
slang terms for psilocybin, such as "shrooms" or "boomers." However, most of these slang terms
also have other meanings and seemed rarely used by the newspapers in this study unless other
terms for psilocybin were also used. For example, a search for "shrooms" in the New York Times
over the study's time period only found 5 articles using this term for psilocybin, but 25 nonpsilocybin uses. Therefore, I did not include these slang terms in my Nexis Uni searches.
There are also a small number of non-psilocybin mushroom species that have
hallucinogenic compounds (such as muscimol, which is found in some Amanita species). There
would therefore seem to be at least some risk that terms such as "hallucinogenic mushrooms" or
"psychedelic mushrooms" might refer to these species rather than psilocybin species. For
example, 4 out of 308 New York Times articles in the Nexis Uni search results referred to these
mushrooms and had no references to psilocybin mushrooms. To avoid this problem, I removed
articles from the Nexis Uni sets of each newspaper if they only referred to non-psilocybin
mushrooms.
I removed duplicate articles from the sets, even if they had different date lines. Nexis Uni
has a functionality to filter out duplicate articles, but it was only sporadically successful, so
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manual removal of duplicates was also necessary. However, multiple articles about the same
news event were included as long as the articles seemed independently written (for example,
following new developments in the event or approaching it from a different perspective). I
counted the number of articles in which a term occurred, not each individual occurrence of a
term. Some articles used more than one term, which is why the overall number of articles in each
newspaper's set is lower than the number resulting from adding together the articles in each term
category. It is also important to note that many of these articles do not have psilocybin as their
central topic. Many journalistic mentions of psilocybin are made only as parts of articles about
different topics.
After the searches and data cleaning described above, the final total article set consisted
of 534 articles from all four newspapers. Of these, 304 articles were from the New York Times,
89 articles were from the San Diego Union-Tribune, 67 articles were from the St. Louis PostDispatch, and 74 articles were from the Tampa Bay Times.
Determining the sentiment of articles presented challenges. Nexis Uni, for example, has a
feature called "Negative News" that uses algorithms to create a set of only negative articles for a
particular search term. However, the Negative News results for psilocybin were often inaccurate.
As just one example, the Negative News algorithms chose the New York Times article "Cancer
Study of Hallucinogen Hints at New Role for Illegal Drug," (Hoffman) which described studies
that showed psilocybin could help treat depression and anxiety. Yet an article describing patients
using psilocybin to reduce mental illness would seem to be a positive article. I suspect that
Negative News chose this article due to its frequent use of words that often have negative
connotations such as "depression" and "anxiety." Many more examples of incorrect algorithmic
choices could be listed here.
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Even if attempts were made to adjust the negative weight of words in order to fit the
paradigm of psilocybin, algorithms might still have difficulty with nuances. For example, in a
New York Times review (Kakutani) of the book Prozac Nation, the word "depression" was used
with the same definition as the positive article mentioned above, i.e. as a clinical psychological
issue. However, in this context, "depression" was a negative word because the review implied
that the author used psilocybin as a way to ineffectively escape her depression, not to treat it.
To avoid problems with using algorithms to determine the sentiment of articles, I decided
that it was a better option for me to personally read and hand-code every article. Yet there were
still significant risks with this option. For example, I was only a single researcher, which could
result in significant bias about sentiment. Future studies in this area might be improved by
having more than one researcher determine the sentiment of articles. The sentiment analyses of
each researcher could then be compared and perhaps averaged. In addition, there is a risk that the
same researcher could give different sentiment ratings to an article depending on the condition of
their mind at a given moment. A full discussion of the debate between machine and human
judgment is beyond the scope of the present study, touching on the fields of philosophy,
computer science, and logic.
After settling on personally hand-coding every article, other challenges presented
themselves. Take, for example, the New York Times article "Ideas Unlimited, Built to Order"
(Schiesel). This article praised the pleasant effects that psilocybin could have for its users, which
would seem to be positive, but the article also called psilocybin "toxic," which would seem to be
negative. In addition, even articles that were clearly determined to be positive or negative might
have had different degrees of positivity or negativity. For example, a brief article describing an
arrest for psilocybin possession might be negative, but it could be argued that there is more
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negative impact from a longer article about a psilocybin arrest that also details the damaging
impact of that arrest on the life of the accused. It would therefore seem negligent to treat these
two articles identically.
To address these problems, I found inspiration in previous studies about media portrayals
of psychoactive substances. McGinty et al. and Zhang et al. created different thematic categories
in which each article could be assessed. Since their thematic categories were not exactly
applicable to psilocybin, I identified five thematic categories to rate sentiment specifically about
psilocybin. For each category, I personally gave every article a score of -1 (negative), 0 (neutral),
or +1 (positive). I then calculated the total scores in each thematic category for each year for
each newspaper. I also added together the scores in each category to provide a single sentiment
score for each year.
I used five thematic categories as I classified the 534 articles in my study:
1) Legality: Is using psilocybin seen merely as a criminal act (negative) or only
unfortunately illegal (positive)?
2) Mode of Action: Is psilocybin seen as physically damaging (negative) or physically
beneficial (positive)?
3) Personal Impact: Is psilocybin seen as psychologically detrimental (negative) or
psychologically beneficial (positive) to the user?
4) Scientific Integrity: Is psilocybin research considered pseudoscience (negative) or
rigorous and serious (positive)?
5) Social Impact: Is psilocybin seen as detrimental (negative) or beneficial (positive) to
society beyond the user?
To further clarify the difference between mode of action and personal impact, mode of
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action concerns physical effects of psilocybin while personal impact concerns psychological
effects. Returning to the example mentioned above ("Ideas Unlimited, Built to Order" [Schiesel])
I gave a +1 for personal benefit to the praise for psilocybin's pleasant psychological effects, but I
gave a -1 for mode of action to the reference to psilocybin as "toxic."

Website building and programming methodology
I presented my study and full capstone in a website built with the content management
system WordPress and the WordPress theme ResponsiveBlogily. However, ResponsiveBlogily
was not exactly suited for presenting a master's capstone, so I had to personally code substantial
changes to the HTML and CSS. I hand-coded most of the website's data visualizations with a
JSON grammar called Vega-Lite. I used GitHub to store the data tables that were accessed by the
Vega-Lite data visualizations. Code other than HTML and CSS cannot be inserted directly into
WordPress, so I needed to insert the Vega-Lite into the ResponsiveBlogily JavaScript files. The
few data visualizations not coded in Vega-Lite were built with Tableau software, and the
Tableau images were inserted directly into the WordPress text content.

Other works in dialogue with this capstone
Despite the optimism that I presented above, there are some psilocybin advocates today
who are worried about a social and political backlash similar to the 1960s. This group seems to
think that this backlash might result from a major rise in recreational use of psilocybin and/or
efforts to legalize its use without the guidance of trained therapists and doctors. In 2019, the
journalist Michael Pollan, who strongly supports allowing regulated psilocybin use in controlled
settings, wrote an opinion piece in the New York Times expressing worry about the city of
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Denver's recent decriminalization of psilocybin. Pollan wrote: "Great enthusiasm has been
inspired by psychedelic research, and I share it, but we should be mindful of psychedelic history
too, in which exuberance about the potential of these medicines gave way to a political backlash
that set back research, and access, for more than 30 years. It doesn’t have to happen again, but it
could." Thomas Insel, the former head of the National Institute of Mental Health, told a
conference of psychedelic researchers in 2017: "Don't screw this up… the danger of having
someone have a really negative experience and not having put everything in place to be able to
help them… can really poison the well here for everybody, so in this stage, early in chapter 1,
let's be very mindful of risk" (MAPS).
The results of my study provide at least some support for the warnings of this sector of
the psilocybin community. Of the four newspapers that I examined, positivity toward psilocybin
only seemed to significantly rise in the New York Times. In addition, the total number of articles
mentioning psilocybin also only significantly rose in the New York Times. In fact one of the other
newspapers showed a significant downward trend in psilocybin mentions.
I believe that the tepidness of the other three newspapers toward psilocybin could mean
that psilocybin advocates are still a small minority in the United States. Although my study is far
from conclusive and much more research of this topic needs to done, I suspect that most of the
American public remains unaware of the recent positive research about psilocybin.
Psilocybin can have powerful and destabilizing effects on its users. However, many
psilocybin therapists seem to believe that with the right frame of mind, proper setting, and
education, these destabilizing experiences can often be beneficial to users. Without these proper
safety measures, though, psilocybin use has the potential to be very frightening, both to users and
the people around them. If recreational use of psilocybin becomes widespread, then worries
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about these difficult experiences (also known as "bad trips") also might become widespread,
which could precipitate a legal crackdown.

How this capstone relates to my concentration and courses
My track in the MALS program has been in data visualization. Part of what this track is
designed to teach is the creation of visual representations of quantitative data that are not only
easy for viewers to understand but also compelling. In addition, MALS data visualization
students should be able to use data visualizations to enhance understanding of the textual
concepts and research being presented.
My study incorporated three formats of data visualization: heatmaps, line charts, and
trend lines. Here are some examples of each visualization from my study:
Heatmaps

Figure 24: Heatmap showing newspaper sentiment analysis
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Line Charts

Figure 17: Line chart showing yearly changes in terms used
Trend Lines

Figure 25: Trend lines showing yearly changes in article numbers
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I also incorporated fMRI scans from a study by Carhart-Harris et al., which used
visualizations of the human brain to explain data about changes in neural activity:

Figure 1: fMRI scans showing psilocybin's effects on human brains
The MALS program first introduced me to the nuances of data visualization though the
course "Data Visualization Methods" taught by Lev Manovich. From Manovich, I learned how
to build precise visualizations with the software Excel and Tableau. Manovich also focused me
on finding ways to make the visualizations compelling and noticeable (to "pop"). When building
my capstone, I used Excel and Tableau to experiment with a wide array of visualizations for the
data that I collected. After determining which visualizations worked best, I could then code them
for the capstone website with Vega-Lite (a JSON grammar).
The next MALS course that influenced my capstone was "Digital Humanities" with
Matthew Gold and Stephen Brier. Gold and Brier taught me how to use data analysis tools like
Voyant and Palladio to examine text wherever I found it in society. They opened my mind to the
possibilities of using text analysis to discover previously unknown facets of a culture. For one
project, I performed text analysis of several Annual Reports from the Metropolitan Transit
Authority. For another project, I created Palladio data visualizations to explain the development
of works by the artist Henry Rollins. It was the combination of text analysis training from
"Digital Humanities" with visualization software training from "Data Visualization Methods"
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that allowed me to analyze and visualize the data that I collected about newspaper articles for my
capstone. Gold and Brier also taught me to relentlessly critique my data analysis methods in an
attempt to discover biases and try to mitigate them. Some of the impact of this teaching can be
seen in my study's frequent reminders that the results are far from conclusive and that more
research is highly recommended.
Another CUNY Graduate Center course that had a strong impact on my capstone was
"Data Visualization" in the Computer Science department, taught by Ronak Etemadpour. This is
the course that introduced me to Vega-Lite, which was the JSON grammar that I used to code the
data visualizations in my capstone website. Etemadpour also gave me the opportunity to create
websites to display the data visualizations that she assigned, combining my website coding
knowledge of HTML, CSS, and JavaScript with data visualization code from D3.js, Python, and
Vega-Lite. This allowed me to eventually build a website to present my capstone research in a
format that was functional on both desktop and mobile devices for a variety of web browsers.

Evaluation and Continuation
Evaluation of the capstone
The results of my study surprised me. Having read a great deal about optimism in the
psilocybin research and advocacy communities, I was inclined to believe that newspaper
coverage of psilocybin would reflect this. However, the results of my study did not support my
inclinations. Despite my own hope that psilocybin will someday be allowed a legal and open
place in psychiatric therapy, my research has made me realize that this optimism might be
premature. Now my hope is that my results will remind the psilocybin medical and advocacy
communities that they need to be careful. If they let psilocybin deregulation move too quickly or
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unwittingly (or wittingly) help it become a recreational drug, as arguably happened in the 1960s,
the results might be unfortunate. Millions of people could lose the chance to improve their
mental well-being, a vast body of scientific research could be lost, and a tragic number of people
could be imprisoned simply for wanting to become better human beings.
I faced a variety of setbacks during the creation and development of this capstone. For
example, I originally wanted to create a capstone around ketamine therapy, which had helped my
father deal with his post-stroke ailments. I engaged with a number of ketamine clinics about
collaborating. My goal was to create research that combined textual analysis of their websites
and patient materials with anonymized medical data that the clinics had collected about their
patients. However, all of these attempts fell apart because of the clinics' understandable concerns
about protecting the privacy of their patients.
After collaborations with ketamine clinics turned out to not be possible, I decided to
focus on newspaper coverage of ketamine. I determined a time frame for articles to examine,
developed hypotheses about how particular journalistic terms for ketamine might have changed
in popularity, and began compiling some data sets. Then I discovered that Zhang et al. had
already done much of this work in their own study. Their process was too similar for me to stake
out original research with my capstone. After some initial worries, this problem was resolved
when I realized that I could probably switch the focus of my research to psilocybin without
losing much of the essence of my original ketamine focus. Discovering the work of Zhang et al.
then turned out to be a blessing in disguise, because after reading their study and a similar study
by McGinty et al., I realized that my original idea of examining only articles from the New York
Times would probably be too limited.
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Another large challenge came when I discovered that in order to create the multidimensional data visualizations that I planned, the Vega-Lite grammar required CSV data tables
to be arranged in a very non-standard way. This would require me to personally reconfigure
every cell in my data tables to fit Vega-Lite's idiosyncratic method. I briefly considered
completely abandoning Vega-Lite and instead using images of my data visualizations built with
Tableau software. However, my desire to make my capstone website as dynamic as possible led
me back to Vega-Lite, and so I resolved the problem by simply taking the time to personally
reconfigure all of my data tables.

Continuation of the capstone
I plan to continue working on my capstone project after submission for my master's
degree. There are a number of areas in which it can be expanded and improved. For example, it
was beyond the current scope to use political leanings when choosing newspapers (particularly
since the political leaning of a newspaper can change dramatically over a 30-year period). If I
could devise a rigorous method to include political leanings in an analysis of psilocybin
coverage, the results might be more helpful. In addition, it could be revealing to research how
psilocybin coverage will change in newspapers for regions where it has been decriminalized,
such as Denver and Oakland. It might also be helpful to expand newspaper analysis to
psychedelic compounds other than psilocybin. My study was partially inspired by a similar study
about the psychedelic ketamine, and it might be helpful to the psychedelic community to gauge
newspaper coverage of compounds such as lysergic acid diethylamide (LSD) and N,Ndimethyltryptamine (DMT). I am also interested in expanding the parameters of this project
beyond newspapers. A more accurate study in the modern era would probably include podcasts,
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cable news, YouTube channels, social media, and other sources. This was beyond the scope of
the present capstone, but it does not seem unfeasible with additional time and patience.
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